Literature DB >> 30125922

[Contributions to reduce coercion in psychiatric care].

Alexandre Wullschleger, Juliane Mielau, Lieselotte Mahler, Angelika Vandamme, Christiane Montag.   

Abstract

Reduction in coercion in psychiatric treatment requires successful interaction between changes in structural preconditions and therapeutic processes, as well as in individual therapeutic skills and attitudes. The article gives an overview of current approaches and possibilities to minimize the use of coercive interventions and to create non-violent and participative therapeutic settings. These opportunities are discussed against the background of structural and staff resources, social and legal aspects, as well as subjective experience of patients and their right to protection and treatment in phases when freedom of will and self- determination are compromised. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2018        PMID: 30125922     DOI: 10.1055/a-0604-2714

Source DB:  PubMed          Journal:  Fortschr Neurol Psychiatr        ISSN: 0720-4299            Impact factor:   0.752


  3 in total

1.  Prevalence and risk factors for seclusion and restraint in old-age psychiatry inpatient units.

Authors:  Marie Chieze; Stefan Kaiser; Delphine Courvoisier; Samia Hurst; Othman Sentissi; Jérôme Fredouille; Alexandre Wullschleger
Journal:  BMC Psychiatry       Date:  2021-02-08       Impact factor: 3.630

2.  Effects of Recovery-Orientation on the Use of Forced Medication and Maximum Daily Drug Dose: The "Weddinger Modell".

Authors:  Klara Czernin; Felix Bermpohl; Alexandre Wullschleger; Lieselotte Mahler
Journal:  Front Psychiatry       Date:  2021-12-15       Impact factor: 4.157

3.  Effect of standardized post-coercion review session on symptoms of PTSD: results from a randomized controlled trial.

Authors:  Christiane Montag; Lieselotte Mahler; Alexandre Wullschleger; Angelika Vandamme; Juliane Mielau; Lara Renner; Felix Bermpohl; Andreas Heinz
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-11-24       Impact factor: 5.270

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.